Researchers may improve heart attack outcomes by zeroing in on the cellular activity that causes long-lasting damage to the heart.

“This is exciting because it shows that proton therapy offers a way for us to reduce the serious side effects of chemo-radiation and improve patient health and well-being without sacrificing the effectiveness of the therapy,” experts wrote in a recent JAMA Oncology study.

Amyloid plaques have long been the target of Alzheimer’s-focused research, but a new study suggests it may be time to prioritize tau imaging instead.

The go-ahead was granted to the Feinstein Institutes for Medical Research to use Fluorodopa F-18 injections in patients with suspected Parkinson’s syndromes.

Underfunding and a lack of resources have led to significant problems imaging severely injured patients in trauma centers across the UK's health system. The Royal College of Radiologists has called on the government to address the issues.

The new approach offers more comprehensive information with no loss of image quality, and may alter the care landscape for patients with coronary artery disease.

Combining fluorodeoxyglucose PET with high-resolution CT can help predict subtypes of early lung adenocarcinoma—a form of cancer that is on the rise.

With this research, clinicians may further their understanding of which drugs will be most effective for cancer therapy plans.